| Autor: |
Digumarthi V S, Sudhakar, Shveta, Jaishankar, Phanindranath, Regur, Umesh, Kumar, Raghvendra, Singh, Usha, Kabilan, Sree, Namduri, Jaishree, Dhyani, Nalini J, Gupta, Baidyanath, Chakravarthy, Khadilkar, Vaman, Iram, Shabir, Rajesh, Khadgawat, Mamata, Deenadayal, Datar, Chaitanya A, Rima, Dada, Yogendra, Sharma, Anuranjan, Anand, Kumarasamy, Thangaraj |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. 13(4) |
| ISSN: |
1661-5433 |
| Popis: |
Steroidogenic factor 1 (NR5A1/SF1) is a key transcription factor that is known to regulate the development of adrenal glands and gonads and is also involved in steroidogenesis. Several pathogenic NR5A1 variants have been reported to cause 46,XY disorders of sex development (DSD), with varying clinical phenotypes ranging from hypospadias to complete gonadal dysgenesis. Most often, the primary cause of DSD is due to variants in gene(s) related to gonadal development or the steroidogenic pathway. In the present study, we have analyzed 64 cases of 46,XY DSD for pathogenic NR5A1 variants. We report a total of 3 pathogenic variants of which 2 were novel (p.Gly22Ser and p.Ser143Asn) and 1 was already known (p.Ser32Asn). Functional studies have revealed that the 2 mutations p.Gly22Ser and p.Ser32Asn could significantly affect DNA binding and transactivation abilities. Further, these mutant proteins showed nuclear localization with aggregate formation. The third mutation, p.Ser143Asn, showed unspeckled nuclear localization and normal DNA binding, but the ability of transcriptional activation was significantly reduced. In conclusion, we recommend screening for NR5A1 pathogenic variants in individuals with features of 46,XY DSD for better diagnosis and management. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
